Lv1
60 积分 2025-09-09 加入
The incidence of cytokine release syndrome and neurotoxicity of CD19 chimeric antigen receptor-T cell therapy in the patient with acute lymphoblastic leukemia and lymphoma
1年前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
1年前
已完结
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia
1年前
已完结
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells
1年前
已完结
Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALL
1年前
已关闭
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
1年前
已完结
Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation
1年前
已完结
Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia
1年前
已完结
A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
1年前
已完结
皖公网安备34019202002308
